Combined Therapeutics, Inc. — Form D
Combined Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-12. The offering totals $2.0M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-12-12
- Form: D
- Accession: 0001724215-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $250K
- Remaining: $1.8M
- Investors: 4
- Date of first sale: 2017-11-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300496
Issuer
- Name: Combined Therapeutics, Inc.
- CIK: 0001724215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 700 MAIN STREET C/O LABCENTRAL, CAMBRIDGE, MA, 02139
- Phone: (44) 747-050-8164
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Daniel Anderson | Director | Brea, CA |
| Robert Langer | Director | Pittsburgh, PA |
| Pierre Matussiere | Director | Cambridge, MA |
| Romain Micol | Director | Cambridge, MA |
| Justine Ryan | Director | Cambridge, MA |
| Romain Micol | Executive Officer | Cambridge, MA |
More